[THE INVESTOR] On Oct. 4, Sang-A Frontec (089980) increased 1.81 % to 11,250 won (US$ 10.16). It had increased 4.05% through the past month. Standard deviation, the risk index for stock price, was 2.5% over the same period of time over one month.

Compared with its close competitors within the same industry, KOSDAQ, the monthly earnings rate of Sang-A Frontec was proper, while its volatility within 1 month was relatively lower than that of its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 1.6. Though its volatility was not so high, the return-on-risk was low on the whole with a poor earnings rate. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, 3.3, and thus it is hard to say that the industrial comparison performance was positive.

Comparing industry to the market, the KOSDAQ industry including Sang-A Frontec records lower volatility and earning rate than Chemicals. In other words, the industry had less volatility and the returns were also smaller than the market.

From Sept. 28, foreigners have been continuously buying Sang-A Frontec during the past 3 trading days. As a shareholding sum by investor group for the past 4 weeks, foreigners have bought 8,283 shares and institutions have bought 7,290 shares as they turn toward a buying stance. However, during the same period, individuals have sold 15,573 shares as they turn toward a selling stance.

Cumulated shareholdings per investor group (1Mo) Total shareholdings per investor group

By HeRo (hero@heraldcorp.com)

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.